Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders

 
 

SYNAGEVA BIOPHARMA CORP (GEVA) Add to portfolio

1m | 3m | 6m | 1y | 2y | 5y | 10y
Price: $3.04 Metrics
OS: 37.2 M -29 % ROE
Market cap: $113 M -34 % ROIC
Net cash: $711 M $19.13 per share
EV:

 
TTM Valuation
EBITDA ($209) M
EBIT ($215) M
EPS ($6.37)

Recent News + Filings   (All items)

Financial Summary   (All financials)
In millions, except per share itemsDec-31-14Dec-31-13Dec-31-12Dec-31-11Dec-31-10Dec-31-09Dec-31-08Dec-31-07
Revenues6.513.415.02.10.6161.811.415.7
            Revenue growth-51.5%-10.6%612.4%252.8%-99.6%1325.3%-27.8%33.1%
Cost of goods sold-200.7-110.9-59.0-27.8-14.23,843.2-7.8-32.2
Gross profit207.2124.373.929.914.8-3,681.419.247.9
            Gross margin3191.9%929.0%494.4%1425.3%2489.6%-2274.8%169.0%304.5%
Selling, general and administrative54.527.617.49.3    
Research and development142.679.637.317.39.9 4.211.4
General and administrative    3.93,843.27.711.1
EBITA-190.6-93.8-39.8-24.5-13.1-10,264.48.025.6
            EBITA margin-2936.6%-701.6%-266.1%-1167.9%-2205.5%-6342.7%70.7%162.7%
Amortization of intangibles1.52.13.20.5  0.20.2
EBIT-192.1-95.9-43.0-25.0-13.1-10,264.47.825.4
            EBIT margin-2959.5%-717.1%-287.7%-1191.9%-2205.5%-6342.7%68.5%161.5%
Pre-tax income-192.1-95.4-42.9-25.3-10.8-11,420.17.727.8
Income taxes0.50.00.00.00.00.0-0.30.4
            Tax rate  0.0%0.0%0.0%0.0% 1.4%
Net income-192.6-95.5-42.9-25.3-10.8-11,420.18.027.4
            Net margin-2967.5%-713.7%-287.2%-1205.6%-1819.2%-7056.8%70.5%174.4%
 
Diluted EPS($5.89)($3.40)($1.90)($8.58)($338.25)($516.14)$0.36$1.24
Shares outstanding (diluted)32.728.122.63.00.022.122.222.1
 
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy